Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Walensky RP"" wg kryterium: Autor


Tytuł:
Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
Autorzy:
Losina E
Touré H
Uhler LM
Anglaret X
Paltiel AD
Balestre E
Walensky RP
Messou E
Weinstein MC
Dabis F
Freedberg KA
ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA)
Losina, Elena
Touré, Hapsatou
Uhler, Lauren M
Anglaret, Xavier
Paltiel, A David
Balestre, Eric
Walensky, Rochelle P
Messou, Eugène
Pokaż więcej
Źródło:
PLoS Medicine; Oct2009, Vol. 6 Issue 10, pe1000173-e1000173, 1p
Czasopismo naukowe
Tytuł:
Diet, physical activity, and obesity among ART-experienced people with HIV in South Africa.
Autorzy:
Hyle EP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Martey EB; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
Bekker LG; Desmond Tutu HIV Centre, Institute of Infectious Disease & Molecular Medicine and Department of Medicine Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Xu A; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Parker RA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Walensky RP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Middelkoop K; Desmond Tutu HIV Centre, Institute of Infectious Disease & Molecular Medicine and Department of Medicine Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło:
AIDS care [AIDS Care] 2023 Jan; Vol. 35 (1), pp. 71-77. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/complications
Humans ; Pregnancy ; Female ; South Africa/epidemiology ; Cross-Sectional Studies ; Obesity/epidemiology ; Obesity/complications ; Diet ; Exercise
Czasopismo naukowe
Tytuł:
The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad.
Autorzy:
Bangs AC; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Gastañaduy P; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Neilan AM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of General Academic Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Fiebelkorn AP; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Walker AT; Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Rao SR; MGH Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Ryan ET; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Travelers' Advice and Immunization Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
LaRocque RC; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Travelers' Advice and Immunization Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Walensky RP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Hyle EP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Travelers' Advice and Immunization Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2022 Jun 22; Vol. 11 (6), pp. 257-266.
Typ publikacji:
Journal Article
MeSH Terms:
Measles*/prevention & control
Mumps*/prevention & control
Rubella*/prevention & control
Child ; Child, Preschool ; Cost-Benefit Analysis ; Humans ; Infant ; Measles-Mumps-Rubella Vaccine ; United States/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł:
A cohort study to assess a communication intervention to improve linkage to HIV care in Nakivale Refugee Settlement, Uganda.
Autorzy:
O'Laughlin KN; Department of Emergency Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.
Xu A; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Greenwald KE; Harvard Affiliated Emergency Medicine Residency, Boston, MA, USA.
Kasozi J; United Nations High Commissioner for Refugees, Representation in Uganda, Kampala, Uganda.
Parker RA; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Bustamante N; Epidemic Intelligence Service, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Parmar P; Division of Global Emergency Medicine, Department of Emergency Medicine, University of Southern California, Los Angeles, CA, USA.
Faustin ZM; Bugema University, Kampala, Uganda.
Walensky RP; Department of Medicine, Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.; Division of Infectious Diseases, Brigham & Women's Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Bassett IV; Department of Medicine, Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Global public health [Glob Public Health] 2021 Dec; Vol. 16 (12), pp. 1848-1855. Date of Electronic Publication: 2020 Nov 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/prevention & control
Refugees*
Cohort Studies ; Communication ; Humans ; Uganda
Czasopismo naukowe
Tytuł:
Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d'Ivoire Modeling Analysis.
Autorzy:
Neilan AM; Division of General Academic Pediatrics, Department of Pediatrics, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Cohn J; Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Sacks E; Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.; Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Gandhi AR; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Fassinou P; Elizabeth Glaser Pediatric AIDS Foundation, Abidjan, Côte d'Ivoire.
Walensky RP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Kouadio MN; Elizabeth Glaser Pediatric AIDS Foundation, Abidjan, Côte d'Ivoire.
Freedberg KA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ciaranello AL; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2021 May 13; Vol. 8 (6), pp. ofab225. Date of Electronic Publication: 2021 May 13 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts.
Autorzy:
Gonsalves GS; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.; Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut, USA.
David Paltiel A; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA.; Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut, USA.
Thornhill T; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.; Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut, USA.
Iloglu S; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.; Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut, USA.
DeMaria A Jr; Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
Cranston K; Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
Monina Klevens R; Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts, USA.
Walensky RP; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Warren JL; Department of Biostatistics, Yale School of Public Health, Connecticut, USA.; Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2021 Mar 15; Vol. 8 (6), pp. ofab128. Date of Electronic Publication: 2021 Mar 15 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results.
Autorzy:
Dugdale CM; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Anahtar MN; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Chiosi JJ; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Lazarus JE; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
McCluskey SM; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Ciaranello AL; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Gogakos T; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Little BP; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Branda JA; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Shenoy ES; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
Walensky RP; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Zachary KC; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
Hooper DC; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
Turbett SE; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Hyle EP; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Nov 24; Vol. 8 (1), pp. ofaa559. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2021).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa.
Autorzy:
Dugdale CM; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Harvard Medical School, Boston, MA, United States of America.
Phillips TK; Division of Epidemiology and Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.; Centre for Infectious Diseases Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
Myer L; Division of Epidemiology and Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.; Centre for Infectious Diseases Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
Hyle EP; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Harvard Medical School, Boston, MA, United States of America.
Brittain K; Division of Epidemiology and Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.; Centre for Infectious Diseases Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
Freedberg KA; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Harvard Medical School, Boston, MA, United States of America.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
Cunnama L; Health Economics Unit, School of Public Health & Family Medicine, University of Cape Town, South Africa.
Walensky RP; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Harvard Medical School, Boston, MA, United States of America.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States of America.
Zerbe A; ICAP at Columbia and the Mailman School of Public Health, Columbia University, New York, NY, United States of America.
Weinstein MC; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
Abrams EJ; ICAP at Columbia and the Mailman School of Public Health, Columbia University, New York, NY, United States of America.; College of Physicians & Surgeons, Columbia University, New York, NY, United States of America.
Ciaranello AL; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Harvard Medical School, Boston, MA, United States of America.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States of America.
Pokaż więcej
Corporate Authors:
MCH-ART Trial Team
Źródło:
PloS one [PLoS One] 2019 Nov 15; Vol. 14 (11), pp. e0225104. Date of Electronic Publication: 2019 Nov 15 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cost-Benefit Analysis*
Infant Care*
Maternal-Child Health Services*
Postnatal Care*
HIV Infections/*epidemiology
Adult ; Antiretroviral Therapy, Highly Active ; Child ; Female ; HIV Infections/drug therapy ; Humans ; Infant ; Male ; Pregnancy ; South Africa/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.
Autorzy:
Ouattara EN; Centre Inserm 1219, University of Bordeaux, Bordeaux, France.; Interdepartmental Centre of Tropical Medicine and Clinical International Health, Division of Infectious and Tropical Diseases, Department of Medicine, University Hospital Centre, Bordeaux, France.; Programme PAC-CI/ANRS Research Site, CHU de Treichville, Abidjan, Côte d'Ivoire.
MacLean RL; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, United States of America.
Danel C; Centre Inserm 1219, University of Bordeaux, Bordeaux, France.; Programme PAC-CI/ANRS Research Site, CHU de Treichville, Abidjan, Côte d'Ivoire.
Borre ED; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, United States of America.
Gabillard D; Centre Inserm 1219, University of Bordeaux, Bordeaux, France.
Huang M; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, United States of America.
Moh R; Programme PAC-CI/ANRS Research Site, CHU de Treichville, Abidjan, Côte d'Ivoire.
Paltiel AD; Yale School of Public Health, New Haven, CT, United States of America.
Eholié SP; Programme PAC-CI/ANRS Research Site, CHU de Treichville, Abidjan, Côte d'Ivoire.
Walensky RP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States of America.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, United States of America.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, United States of America.
Anglaret X; Centre Inserm 1219, University of Bordeaux, Bordeaux, France.; Programme PAC-CI/ANRS Research Site, CHU de Treichville, Abidjan, Côte d'Ivoire.
Freedberg KA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, United States of America.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States of America.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States of America.; Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, United States of America.; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.; Department of Epidemiology, Boston University School of Public Health, Boston, MA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jun 27; Vol. 14 (6), pp. e0219068. Date of Electronic Publication: 2019 Jun 27 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents/*administration & dosage
Anti-HIV Agents/*economics
HIV Infections/*drug therapy
HIV Infections/*economics
Adolescent ; Adult ; Budgets ; CD4 Lymphocyte Count ; Cohort Studies ; Computer Simulation ; Cost-Benefit Analysis ; Cote d'Ivoire ; Drug Costs ; Female ; HIV Infections/immunology ; Health Resources/economics ; Humans ; Life Expectancy ; Male ; Middle Aged ; Models, Biological ; Models, Economic ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus.
Autorzy:
Desmonde S; UMR 1027 Inserm, Université Paul Sabatier, Toulouse.; Bordeaux School of Public Health, France.; Medical Practice Evaluation Center, Boston.
Frank SC; Medical Practice Evaluation Center, Boston.; Division of General Internal Medicine, Department of Medicine, Boston.
Coovadia A; Empilweni Service and Research Unit, Johannesburg, South Africa.
Dahourou DL; Bordeaux School of Public Health, France.; Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Hou T; Medical Practice Evaluation Center, Boston.; Division of General Internal Medicine, Department of Medicine, Boston.
Abrams EJ; ICAP at Columbia University, Mailman School of Public Health, and Vagelos College of Physicians & Surgeons, Columbia University, New York.
Amorissani-Folquet M; Division of Pediatrics, University Hospital of Cocody, Abidjan, Cote d'Ivoire.
Walensky RP; Medical Practice Evaluation Center, Boston.; Division of General Internal Medicine, Department of Medicine, Boston.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston.; Center for AIDS Research, Harvard University, Boston.
Strehlau R; Empilweni Service and Research Unit, Johannesburg, South Africa.
Penazzato M; World Health Organization, Geneva, Switzerland.
Freedberg KA; Medical Practice Evaluation Center, Boston.; Division of General Internal Medicine, Department of Medicine, Boston.; Center for AIDS Research, Harvard University, Boston.; Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston.
Kuhn L; Gertrude H. Sergievsky Center, College of Physicians and Surgeons and Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, New York.
Leroy V; UMR 1027 Inserm, Université Paul Sabatier, Toulouse.
Ciaranello AL; Medical Practice Evaluation Center, Boston.; Division of General Internal Medicine, Department of Medicine, Boston.; Harvard Medical School, Boston.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2019 Jun 11; Vol. 6 (7), pp. ofz276. Date of Electronic Publication: 2019 Jun 11 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Using national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa.
Autorzy:
Bassett IV; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Huang M; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Cloete C; McCord Hospital, Durban, South Africa.
Candy S; Department of Academic Affairs, Research and Quality Assurance, Corporate Data Warehouse, National Health Laboratory Services, Johannesburg, South Africa.
Giddy J; McCord Hospital, Durban, South Africa.
Frank SC; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Freedberg KA; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Departments of Epidemiology and Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Losina E; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Departments of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, MA, USA.; Division of Rheumatology, Department of Medicine, and Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Walensky RP; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Parker RA; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Harvard University Center for AIDS Research (CFAR), Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2019 Jun; Vol. 22 (6), pp. e25326.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*therapy
Patient Transfer/*statistics & numerical data
Adult ; Ambulatory Care Facilities/statistics & numerical data ; CD4 Lymphocyte Count ; Female ; HIV Infections/epidemiology ; HIV Infections/immunology ; Humans ; Male ; Middle Aged ; South Africa/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies